OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Natural products reverse cancer multidrug resistance
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Showing 6 citing articles:
Herbal Therapies for Cancer Treatment: A Review of Phytotherapeutic Efficacy
Andrej Jenča, David K. Mills, Hadis Ghasemi, et al.
Biologics (2024) Vol. Volume 18, pp. 229-255
Open Access | Times Cited: 6
Andrej Jenča, David K. Mills, Hadis Ghasemi, et al.
Biologics (2024) Vol. Volume 18, pp. 229-255
Open Access | Times Cited: 6
Study on the Chemical Composition and Multidrug Resistance Reversal Activity of Euphorbia uralensis (Euphorbiaceae)
Yina Ding, Yuhao Liu, Qiang Dang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 412-412
Open Access
Yina Ding, Yuhao Liu, Qiang Dang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 412-412
Open Access
Current Advances in the Therapeutic Potential of Scutellarin: Novel Applications, Mechanisms, and Future Challenges.
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access
Great Iruoghene Edo, Alice Njolke Mafe, Patrick Othuke Akpoghelie, et al.
Phytomedicine Plus (2025), pp. 100754-100754
Open Access
Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells
Peter Werner, Nikoletta Szemerédi, Gabriella Spengler, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 14, pp. 1047-1055
Closed Access
Peter Werner, Nikoletta Szemerédi, Gabriella Spengler, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 14, pp. 1047-1055
Closed Access
Hyrtios sp.-associated Cladosporium sp. UR3 as a potential source of antiproliferative metabolites
Omnia Hesham Abdelhafez, Abeer H. Elmaidomy, Mohamed Hisham, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access
Omnia Hesham Abdelhafez, Abeer H. Elmaidomy, Mohamed Hisham, et al.
BMC Microbiology (2024) Vol. 24, Iss. 1
Open Access
Coley’s Toxin to First Approved Therapeutic Vaccine—A Brief Historical Account in the Progression of Immunobiology-Based Cancer Treatment
K. Devaraja, Manisha Singh, Krishna Sharan, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2746-2746
Open Access
K. Devaraja, Manisha Singh, Krishna Sharan, et al.
Biomedicines (2024) Vol. 12, Iss. 12, pp. 2746-2746
Open Access
Identification and Therapeutic Targeting of METTL8-Mediated Lenvatinib Resistance in Hepatocellular Carcinoma Using Rabdosiin
Yunpeng Liu, Muhua Chen, Xiang-Xu Wang, et al.
Experimental Cell Research (2024), pp. 114389-114389
Closed Access
Yunpeng Liu, Muhua Chen, Xiang-Xu Wang, et al.
Experimental Cell Research (2024), pp. 114389-114389
Closed Access
